Post by Recipharm

Robust IVPT data starts with the right methodology. By tailoring sampling strategies to the formulation and regulatory pathway, IVPT studies can generate reliable, reproducible permeation data that supports more confident decision-making and smoother regulatory submissions. Our latest white paper explores how IVPT methodologies can support more reliable bioequivalence assessments, stronger permeation data and more efficient pathways to market for topical therapies. Download the paper: https://lnkd.in/dTEHYbZ9